NASDAQ · Healthcare · Biotechnology
Kalaris Therapeutics Inc
KLRS
Kalaris Therapeutics Inc. CEO Andrew Oxtoby · Market cap $80.8M.
$4.32
+0.02 · +0.47%
52w hi $11.8852w lo $2.14
Off 52w high 58.6%
68
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Hold
Avg PT $18.25
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 20 | Srinivas Akkaraju | Buy | 244,300 | $4.83 | +$1.18M | 68 | |
| Dec 18 | Srinivas Akkaraju | Buy | 479,847 | $10.42 | +$5.00M | 73 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun